Patients with F508del-CFTR mutations have decreased quantity and function of the CFTR protein (Ratjen et al., 2015) leading to severe disease manifestations, e.g., inborn exocrine pancreatic insufficiency, growth impairment, and progressive lung disease (Ratjen et al., 2015). This evidence concerns the gene CFTR and exocrine pancreatic insufficiency.